Inc. shares have tumbled to a 52-week low, touching down at $0.25, as the company faces a challenging period marked by investor concerns. With a market capitalization of just $5.33 million and an ...
BioCryst Pharmaceuticals Inc (BCRX) stock saw a modest uptick, ending the day at $7.45 which represents a slight increase of $0.39 or 5.52% from the prior close of $7.06. The stock opened at $7.04 and ...